drugset / Trial / NCT04386343

CH1701 for Prevention and Treatment of Radiation Burns

NCT04386343 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

A combined Phase I\&II, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for prevention and treatment of radiation therapy burn of CH1701

Timeline

Start
2019-07-05
Primary completion
2020-12
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator CH1701 Unknown 50 % —
Comparator CH1701 Unknown 100 % —
Comparator CH1701 Unknown 167 % —

Indications